Journey II
Device Recon Knees
PDI 00885556578742
General payments
$4,884,161
Research payments
$190,213
Through program year 2025, $4,884,161 in general payments and $190,213 in research payments were reported against Journey II (Recon Knees).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $2,322,946 | 400 |
| 2025 | Research | $14,811 | 8 |
| 2024 | General | $2,103,597 | 310 |
| 2024 | Research | $24,494 | 12 |
| 2023 | General | $224,567 | 634 |
| 2023 | Research | $22,169 | 19 |
| 2022 | General | $233,051 | 462 |
| 2022 | Research | $128,739 | 21 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 30 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,806 general · 60 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.